Migraine trials in Romania

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

  Where

  Bucharest, Bucuresti, Cluj-Napoca, Sibiu

  Age

  6 years to 17 years

  People

  450 worldwide

  Run by

  AbbVie

  See details and how to joinNCT05711394 · EU 2022-501100-94-00
• Phase 3Enrolling by invitation
  Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine

  Where

  Bucharest, Bucuresti, Cluj-Napoca

  Age

  6 years to 17 years

  People

  650 worldwide

  Run by

  AbbVie

  See details and how to joinNCT05707949 · EU 2022-501099-24-00